• 1
    Terkeltaub R. Diseases associated with articular deposition of calcium pyrophosphate dihydrate and basic calcium phosphate crystals. In: HarrisE, editor. Textbook of rheumatology. Philadelphia: Elsevier Saunders; 2005. p. 143048.
  • 2
    Doherty M. Calcium pyrophosphate dihydrate crystal-associated arthropathy. In: HochbergM, SilmanA, SmolenJ, WeinblattM, WeismanM, editors. Rheumatology. 4th ed. Philadelphia: Elsevier Saunders; 2003. p. 193750.
  • 3
    Zaka R, Williams CJ. Genetics of chondrocalcinosis. Osteoarthritis Cartilage 2005; 13: 74550.
  • 4
    Jones AC, Chuck AJ, Arie EA, Green DJ, Doherty M. Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum 1992; 22: 188202.
  • 5
    Chaisson CE, McAlindon TE, Felson DT, Naimark A, Wilson PW, Sawin CT. Lack of association between thyroid status and chondrocalcinosis or osteoarthritis: the Framingham Osteoarthritis Study. J Rheumatol 1996; 23: 7115.
  • 6
    Calo L, Punzi L, Semplicini A. Hypomagnesemia and chondrocalcinosis in Bartter's and Gitelman's syndrome: review of the pathogenetic mechanisms. Am J Nephrol 2000; 20: 34750.
  • 7
    Cobeta-Garcia JC, Gascon A, Iglesias E, Estopinan V. Chondrocalcinosis and Gitelman's syndrome: a new association? [letter]. Ann Rheum Dis 1998; 57: 7489.
  • 8
    Gascon A, Cobeta-Garcia JC, Iglesias E. Hypomagnesemia and chondrocalcinosis in Gitelman syndrome [letter]. Am J Med 1999; 107: 3012.
  • 9
    Hisakawa N, Yasuoka N, Itoh H, Takao T, Jinnouchi C, Nishiya K, et al. A case of Gitelman's syndrome with chondrocalcinosis. Endocr J 1998; 45: 2617.
  • 10
    Munoz-Fernandez S, Pantoja L, Martin Mola E, de Miguel E, Gijon Banos J. Chondrocalcinosis associated with Bartter's syndrome and hypomagnesemia. J Rheumatol 1994; 21: 17823.
  • 11
    Perez-Ruiz F, Testillano M, Gastaca MA, Herrero-Beites AM. “Pseudoseptic” pseudogout associated with hypomagnesemia in liver transplant patients. Transplantation 2001; 71: 6968.
  • 12
    Punzi L, Calo L, Schiavon F, Pianon M, Rosada M, Todesco S. Chondrocalcinosis is a feature of Gitelman's variant of Bartter's syndrome: a new look at the hypomagnesemia associated with calcium pyrophosphate dihydrate crystal deposition disease. Rev Rhum Engl Ed 1998; 65: 5714.
  • 13
    Salvarani C, Rossi F, Macchioni PL, Baricchi R, Capozzoli N, Castellani S, et al. Bartter's syndrome and chondrocalcinosis: a possible role for hypomagnesemia in the deposition of calcium pyrophosphate dihydrate (CPPD) crystals. Clin Exp Rheumatol 1989; 7: 41520.
  • 14
    Smilde TJ, Haverman JF, Schipper P, Hermus AR, van Liebergen FJ, Jansen JL, et al. Familial hypokalemia/hypomagnesemia and chondrocalcinosis. J Rheumatol 1994; 21: 15159.
  • 15
    Richette P, Ayoub G, Bardin T, Bouvet S, Orcel P, Badran AM. Hypomagnesemia and chondrocalcinosis in short bowel syndrome. J Rheumatol 2005; 32: 24346.
  • 16
    Weisinger JR, Bellorin-Font E. Magnesium and phosphorus. Lancet 1998; 352: 3916.
  • 17
    Weiss-Guillet EM, Takala J, Jakob SM. Diagnosis and management of electrolyte emergencies. Best Pract Res Clin Endocrinol Metab 2003; 17: 62351.
  • 18
    Rude RK. Magnesium deficiency: a cause of heterogeneous disease in humans. J Bone Miner Res 1998; 13: 74958.
  • 19
    Basso LE, Ubbink JB, Delport R. Erythrocyte magnesium concentration as an index of magnesium status: a perspective from a magnesium supplementation study. Clin Chim Acta 2000; 291: 18.
  • 20
    Agus ZS. Hypomagnesemia. J Am Soc Nephrol 1999; 10: 161622.
  • 21
    Cohen-Solal M, Baudoin C, Joly F, Vahedi K, D'Aoust L, de Vernejoul MC, et al. Osteoporosis in patients on long-term home parenteral nutrition: a longitudinal study. J Bone Miner Res 2003; 18: 198994.
  • 22
    Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494502.
  • 23
    Resnick D, Niwayama G. Calcium pyrophosphate dihydrate crystal deposition disease. In: MankeD, editor. Diagnosis of bone and joint disorders. 2nd ed. Philadelphia: Saunders; 1988. p. 1673732.
  • 24
    Nightingale JM. Management of patients with a short bowel. World J Gastroenterol 2001; 7: 74151.
  • 25
    Sundaram A, Koutkia P, Apovian CM. Nutritional management of short bowel syndrome in adults. J Clin Gastroenterol 2002; 34: 20720.
  • 26
    Martinez-Riquelme A, Rawlings J, Morley S, Kendall J, Hosking D, Allison S. Self-administered subcutaneous fluid infusion at home in the management of fluid depletion and hypomagnesaemia in gastro-intestinal disease. Clin Nutr 2005; 24: 15863.
  • 27
    Ross JR, Dargan PI, Jones AL, Kostrzewski A. A case of hypomagnesaemia due to malabsorption, unresponsive to oral administration of magnesium glycerophosphate, but responsive to oral magnesium oxide supplementation. Gut 2001; 48: 8578.
  • 28
    Felson DT, Anderson JJ, Naimark A, Kannel W, Meenan RF. The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham study. J Rheumatol 1989; 16: 12415.
  • 29
    Sanmarti R, Panella D, Brancos MA, Canela J, Collado A, Brugues J. Prevalence of articular chondrocalcinosis in elderly subjects in a rural area of Catalonia. Ann Rheum Dis 1993; 52: 41822.
  • 30
    Neame RL, Carr AJ, Muir K, Doherty M. UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis 2003; 62: 5138.
  • 31
    Zhang W, Neame R, Doherty S, Doherty M. Relative risk of knee chondrocalcinosis in siblings of index cases with pyrophosphate arthropathy. Ann Rheum Dis 2004; 63: 96973.
  • 32
    Malaviya AN, Al-Shari IM, Al-Shayeb AR, Shehab D, Hussain MA, Al-Mutairy M, et al. Calcium pyrophosphatase dihydrate (CPPD) crystal deposition disease in a teaching hospital in Kuwait. Ann Rheum Dis 2001; 60: 4169.
  • 33
    Canhao H, Fonseca JE, Leandro MJ, Romeu JC, Pimentao JB, Costa JT, et al. Cross-sectional study of 50 patients with calcium pyrophosphate dihydrate crystal arthropathy. Clin Rheumatol 2001; 20: 11922.
  • 34
    Al-Ghamdi SM, Cameron EC, Sutton RA. Magnesium deficiency: pathophysiologic and clinical overview. Am J Kidney Dis 1994; 24: 73752.
  • 35
    Rynes RI, Merzig EG. Calcium pyrophosphate crystal deposition disease and hyperparathyroidism: a controlled, prospective study. J Rheumatol 1978; 5: 4608.
  • 36
    Ellman MH, Brown NL, Porat AP. Laboratory investigations in pseudogout patients and controls. J Rheumatol 1980; 7: 7781.
  • 37
    Ea HK, Blanchard A, Dougados M, Roux C. Chondrocalcinosis secondary to hypomagnesemia in Gitelman's syndrome. J Rheumatol 2005; 32: 18402.
  • 38
    Jin-no Y, Kamiya Y, Okada M, Hirako M, Takada N, Kawaguchi M. Primary hypomagnesemia caused by isolated magnesium malabsorption: atypical case in adult. Intern Med 1999; 38: 2615.
  • 39
    Doherty M, Dieppe P. Double blind, placebo controlled trial of magnesium carbonate in chronic arthropathy. Ann Rheum Dis 1983; 42 Suppl 1: 1067.